These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46 related articles for article (PubMed ID: 22752249)
1. Synthetic small peptides acting on B7H1 enhance apoptosis in pancreatic cancer cells. Wang F; Ma J; Liu J; Jin H; Huang D Mol Med Rep; 2012 Sep; 6(3):553-7. PubMed ID: 22752249 [TBL] [Abstract][Full Text] [Related]
2. Interferon-γ-induced PD-L1 surface expression on human oral squamous carcinoma via PKD2 signal pathway. Chen J; Feng Y; Lu L; Wang H; Dai L; Li Y; Zhang P Immunobiology; 2012 Apr; 217(4):385-93. PubMed ID: 22204817 [TBL] [Abstract][Full Text] [Related]
4. B7H1/CD80 interaction augments PD-1-dependent T cell apoptosis and ameliorates graft-versus-host disease. Deng R; Cassady K; Li X; Yao S; Zhang M; Racine J; Lin J; Chen L; Zeng D J Immunol; 2015 Jan; 194(2):560-74. PubMed ID: 25488990 [TBL] [Abstract][Full Text] [Related]
5. Expression of costimulatory molecules on human retinoblastoma cells Y-79: functional expression of CD40 and B7H1. Usui Y; Okunuki Y; Hattori T; Takeuchi M; Kezuka T; Goto H; Usui M Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4607-13. PubMed ID: 17003458 [TBL] [Abstract][Full Text] [Related]
6. S100P promotes pancreatic cancer growth, survival, and invasion. Arumugam T; Simeone DM; Van Golen K; Logsdon CD Clin Cancer Res; 2005 Aug; 11(15):5356-64. PubMed ID: 16061848 [TBL] [Abstract][Full Text] [Related]
7. The JAK/STAT pathway is involved in the upregulation of PD-L1 expression in pancreatic cancer cell lines. Doi T; Ishikawa T; Okayama T; Oka K; Mizushima K; Yasuda T; Sakamoto N; Katada K; Kamada K; Uchiyama K; Handa O; Takagi T; Naito Y; Itoh Y Oncol Rep; 2017 Mar; 37(3):1545-1554. PubMed ID: 28112370 [TBL] [Abstract][Full Text] [Related]
8. Transplantation of NIT-1 cells expressing pD-L1 for treatment of streptozotocin-induced diabetes. Wen X; Zhu H; Li L; Li Y; Wang M; Liu J; Yang D; Liao W; Shen G Transplantation; 2008 Dec; 86(11):1596-602. PubMed ID: 19077895 [TBL] [Abstract][Full Text] [Related]
9. Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference. Wang J; Shi YQ; Yi J; Ye S; Wang LM; Xu YP; He M; Kong XM J Dig Dis; 2008 Nov; 9(4):228-37. PubMed ID: 18959596 [TBL] [Abstract][Full Text] [Related]
11. Regulation of the resistance to TRAIL-induced apoptosis as a new strategy for pancreatic cancer. Mori T; Doi R; Toyoda E; Koizumi M; Ito D; Kami K; Kida A; Masui T; Kawaguchi Y; Fujimoto K Surgery; 2005 Jul; 138(1):71-7. PubMed ID: 16003319 [TBL] [Abstract][Full Text] [Related]
12. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer. Baker AF; Koh MY; Williams RR; James B; Wang H; Tate WR; Gallegos A; Von Hoff DD; Han H; Powis G Pancreas; 2008 Mar; 36(2):178-86. PubMed ID: 18376310 [TBL] [Abstract][Full Text] [Related]
13. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression. Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells. Wang P; Zhang J; Bellail A; Jiang W; Hugh J; Kneteman NM; Hao C Cell Signal; 2007 Nov; 19(11):2237-46. PubMed ID: 17693058 [TBL] [Abstract][Full Text] [Related]
15. HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA). Mehdi O; Françoise S; Sofia CL; Urs G; Kevin Z; Bernard S; Igor S; Anabela CD; Dominique L; Eric M; Ali O Pancreatology; 2012; 12(2):146-55. PubMed ID: 22487525 [TBL] [Abstract][Full Text] [Related]
16. Effect of the XIAP inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer cells. Mori T; Doi R; Kida A; Nagai K; Kami K; Ito D; Toyoda E; Kawaguchi Y; Uemoto S J Surg Res; 2007 Oct; 142(2):281-6. PubMed ID: 17640673 [TBL] [Abstract][Full Text] [Related]
17. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells. Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215 [TBL] [Abstract][Full Text] [Related]
18. Tumor PD-L1 co-stimulates primary human CD8(+) cytotoxic T cells modified to express a PD1:CD28 chimeric receptor. Prosser ME; Brown CE; Shami AF; Forman SJ; Jensen MC Mol Immunol; 2012 Jul; 51(3-4):263-72. PubMed ID: 22503210 [TBL] [Abstract][Full Text] [Related]
19. [Activation of multiple tumor suppressor genes by MBD1 siRNA in pancreatic cancer cell line BxPC-3]. Xu J; Liu C; Yu XJ; Jin C; Fu DL; Ni QX Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1948-51. PubMed ID: 19062732 [TBL] [Abstract][Full Text] [Related]
20. Chemopreventive agents induce programmed death-1-ligand 1 (PD-L1) surface expression in breast cancer cells and promote PD-L1-mediated T cell apoptosis. Zhang P; Su DM; Liang M; Fu J Mol Immunol; 2008 Mar; 45(5):1470-6. PubMed ID: 17920123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]